Connecting researchers with the infrastructure and expertise to drive discovery.
Compounds Australia's Members form a diverse national and international community of academic and commercial research organisations united by a shared goal of advancing drug discovery.
Through our unique access model, Members gain access to specialised compound management infrastructure, compound libraries, and expertise that would be difficult and costly to establish independently, accelerating research while maximising the value of existing investments.
Most Australian universities and medical research organisations are Members of Compounds Australia. Contact us to find out whether your organisation is already a Member or to learn how to join.
Why become a member?
As a not-for-profit national research facility supported by funding partners including NCRIS-enabled Therapeutic Innovation Australia (TIA), Compounds Australia provides cost-effective access to specialised drug discovery infrastructure and expertise. Our unique model delivers a scalable and affordable pathway to capabilities that would be difficult and costly for individual organisations to establish and maintain.
Enabling researcher-owned innovation
Compounds Australia facilitates resource sharing and collaboration across the research community while making no claim on intellectual property, ensuring Members retain full ownership of their discoveries and innovations.
Access nationally significant infrastructure
As Australia's only facility dedicated to complex compound management, Compounds Australia provides access to specialised infrastructure, expertise, and services that support more than 250 research teams across ~50 member organisations each year.
Connected drug discovery capabilities
Compounds Australia provides streamlined access to a network of partnered screening and drug discovery facilities, helping researchers efficiently progress from compound management and screening through to hit identification and lead optimisation.
Flexible, open, and accessible
Membership is open to any organisation and carries no joining fee. Pre-agreed terms and transparent fee-for-service pricing enable rapid project commencement and progression, with researchers paying only for the services they use.
Member resources
Ordering from Compounds Australia
1. Contact us to discuss and review your requirements, including:
- Compound selection – For the Open Access Collection, review the curated libraries or search for specific criteria on Smart Compounds.
- Labware – Compounds Australia can dispense into a wide range of 96-, 384-, and 1536-well plates.
- Plate templates – We have an extensive selection of 96-, 384-, and 1536-well plates templates to choose from, including single-point, dose-response, and replicates. New templates can be created on request.
- Pricing – We will work with you to generate the most efficient workflows to meet your needs.
2. The Compounds Australia team will:
- Configure the job in iLab and forward to you for approval.
- Schedule your job – Standard processing is within 3 weeks of job approval, with priority processing available on request (with priority fee).
3. You will receive:
- On completion of processing – a plate map emailed to you directly from Compounds Australia’s LIMS (mosaic-cloud), with details of the completed plating.
- On scheduled delivery day – your plates will be delivered by courier.
Lodging samples with Compounds Australia
1. Contact us to discuss and review your requirements.
- Sample state – Samples can be submitted in vials or plates, and as solids or DMSO-solubilised.
- Storage format – Microtubes and/or microplates.
2. We will work with you to:
- Develop a storage model based on the number and amount of sample, length of storage, and anticipated usage.
- Register sample details into LIMS for inventory management.
- Schedule any processing (eg. re-formats) or analysis (eg. LC-MS) on deposition.
3. Send your samples (along with any details required) to:
+61 (7) 3735 4445
4. You will receive:
- Unique Sample Number ( SN ) for each of your samples held at the facility.
- Inventory and usage reports – annually or on request.
National Collaborative Research Infrastructure Strategy
Compounds Australia, through Therapeutic Innovation Australia (TIA), is part of the National Collaborative Research Infrastructure Strategy (NCRIS), a network of world-class research infrastructure facilities that drives and supports greater innovation in the Australian research sector and associated economic impact. Compounds Australia is a member to the TIA Small Molecule capability, an integrated capability network of National Research Infrastructure, available to support researchers through the TIA Pipeline Accelerator programs.
Acknowledging Compounds Australia
Compounds Australia provides subsidised access to world-class compound management infrastructure and expertise through the support of our funding partners. To help us maintain these capabilities and continue delivering cost-effective services to the research community, we require that all researchers acknowledge Compounds Australia and our funding partners in publications, presentations, reports, and other research outputs arising from work supported by the facility.
Acknowledgements are an important way of demonstrating the impact of national research infrastructure and help ensure these valuable capabilities remain available to researchers into the future.
If Compounds Australia has contributed to your research, please include the following acknowledgement:
"We acknowledge Compounds Australia (www.compoundsaustralia.com) for their provision of specialised compound management and logistics research services to the project."
Explore our capabilities and expertise
Contact details
- Phone
- (07) 3735 4445
- Location and postal address
- Compounds Australia
- Institute for Biomedicine and Glycomics
- Griffith University
- Building N75
- Brisbane Innovation Park
- Don Young Road
- Nathan QLD 4111
